Ensign Peak Advisors
MYOV

Ensign Peak Advisors’s Myovant Sciences Ltd. MYOV Stock Holding History

Ensign Peak Advisors’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,100
Closed -$289K – 2320
2022
Q3 		$289K Buy
16,100
+6,480
+67% +$103K ﹤0.01% 1720
2022
Q2 		$120K Hold
9,620
– – ﹤0.01% 1927
2022
Q1 		$128K Hold
9,620
– – ﹤0.01% 1985
2021
Q4 		$150K Buy
+9,620
New +$184K ﹤0.01% 1986
2021
Q1 		– Sell
-29,673
Closed -$820K – 1897
2020
Q4 		$820K Hold
29,673
– – ﹤0.01% 1479
2020
Q3 		$417K Buy
+29,673
New +$552K ﹤0.01% 1574

Other funds holding MYOV

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ensign Peak Advisors's MYOV Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 16,100 shares — an estimated $289K sold.

Ensign Peak Advisors first reported a position in MYOV in Q3 2020 and held it in 6 quarters. The position peaked at $820K in Q4 2020. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • Ensign Peak Advisors reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 16,100 Myovant Sciences Ltd. shares in Q4 2022, an estimated $289K.
  • Ensign Peak Advisors first reported a position in Myovant Sciences Ltd. in Q3 2020 and held it in 6 quarters.
  • Ensign Peak Advisors's Myovant Sciences Ltd. position peaked at $820K in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.